EasySep™小鼠TIL（CD45）正选试剂盒
Scientific Resources
-
ReferenceHybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal.细胞类型：
CD4+ T 细胞
研究方向：
HIV
-
ReferenceCombinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation.
品牌：
EasySep
细胞类型：
CD4+ T 细胞
研究方向：
HIV
-
ReferenceGenetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.
细胞类型：
CD4+ T 细胞
研究方向：
HIV
-
-
ReferenceHIV Protease Inhibitor-Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation.
品牌：
EasySep
细胞类型：
CD4+ T 细胞
研究方向：
HIV 免疫
-
ReferenceComparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils.
品牌：
EasySep
细胞类型：
NK 细胞 T 细胞 单核细胞 粒细胞及其亚群
研究方向：
HIV 免疫
-
ReferenceIn vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients.
品牌：
RosetteSep
细胞类型：
CD4+ T Cells T 细胞
研究方向：
HIV
-
ReferenceHIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.
品牌：
RosetteSep
细胞类型：
T 细胞
研究方向：
HIV
-
ReferenceCytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells.
品牌：
EasySep
细胞类型：
T 细胞
研究方向：
HIV 免疫
-
ReferenceMemory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells.
品牌：
EasySep
细胞类型：
CD8+ T 细胞
研究方向：
HIV 免疫
-
ReferenceAlternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells.
品牌：
EasySep
细胞类型：
B 细胞 T 细胞
研究方向：
HIV 免疫
-
ReferenceLysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.
品牌：
EasySep
细胞类型：
NK 细胞 T 细胞
研究方向：
HIV 免疫
